Roche Platform Transition
This page compares reference ranges between the Roche and Beckman platforms for the selected category of tests. For a description of the transition from the Beckman to Roche automated chemistry platform, please see the Chemistry and Immunoassay Beckman to Roche Transition Guideline.
Method Comparison
The comparison table contains the following columns:
- Trendable?: Indicates whether both methods use the same component code and results are trendable in Epic.
- Bias: The average absolute difference between Roche and Beckman results. A positive value means Roche results are higher on average.
- Percent Bias: Blue shading and bars extending left indicate negative bias (Beckman higher on average); orange shading and bars extending right indicate positive bias (Roche higher on average). Longer bars indicate greater magnitude.
- Slope: The slope of the linear regression of Roche onto Beckman, representing proportional bias between the methods. “Not comparable” indicates that the methods were too poorly correlated for direct patient-result comparison.
- R2 (Coefficient of Determination): How closely the regression fits the paired results.
These data can help when comparing results across platforms, but should not be used to convert a result directly from one method to the other.
| Test Name | Beckman | Roche | Trendable? | Bias | Percent Bias | Slope | Coefficient of Determination (R2) |
|---|---|---|---|---|---|---|---|
| Alpha Fetoprotein, Nonmaternal | AFPNOT | AFPTRD | ❌ | Not comparable | |||
| Beta 2 Microglobulin, Serum | BETA2 | BETA2 | ✅ | 0.31 mcg/mL | 12.48% | 0.88 | 0.9622 |
| CA 125 | CA125R | C125RD | ❌ | Not comparable | |||
| CA 15.3 | CA153R | C153RD | ❌ | Not comparable | |||
| CA 19.9 | CA199 | C199RD | ❌ | Not comparable | |||
| Carcinoembryonic Antigen | CEA | CEARD | ❌ | Not comparable | |||
| Prostate Specific Antigen | PSA | PSARD | ❌ | Not comparable | |||
| Prostate Specific Antigen Screen | PSASCR | PSASRD | ❌ | Not comparable | |||
| Prostate Specific Antigen, Free | PSAF | PSAFRD | ❌ | Not comparable |
Reference Ranges
Name
Beckman
Roche
Alpha Fetoprotein, Nonmaternal
Name: Alpha Fetoprotein, Nonmaternal (Beckman)
Mnemonic: AFPNOT
Units: ng/mL
Method Code: default
Effective date: 08/14/2009
Mnemonic: AFPNOT
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 3y- | 0.0-8.5 | 3y- | 0.0-8.5 |
Name: Alpha Fetoprotein, Nonmaternal (Roche)
Mnemonic: AFPTRD
Units: ng/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: AFPTRD
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0.0-8.2 | 0- | 0.0-8.2 |
Beta 2 Microglobulin, Serum
Name: Beta 2 Microglobulin, Serum
Mnemonic: BETA2
Units: mcg/mL (units differ between platforms)
Method Code: default
Effective date: 09/14/2026
Mnemonic: BETA2
Units: mcg/mL (units differ between platforms)
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0-59y | 0.8-2.4 | 0-59y | 0.8-2.4 |
| 60y- | 0.0-3.0 | 60y- | 0.0-3.0 |
Name: Beta 2 Microglobulin, Serum
Mnemonic: BETA2
Mnemonic: BETA2
CA 125
Name: CA 125 (Beckman)
Mnemonic: CA125R
Units: U/mL
Method Code: default
Effective date: 03/01/2016
Mnemonic: CA125R
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-35 | 0- | 0-35 |
Name: CA 125 (Roche)
Mnemonic: C125RD
Units: U/mL
Method Code: default
Effective date: 04/19/2026
Mnemonic: C125RD
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-38 | 0- | 0-38 |
CA 15.3
Name: CA 15.3 (Beckman)
Mnemonic: CA153R
Units: U/mL
Method Code: default
Effective date: 10/17/2016
Mnemonic: CA153R
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-20 | 0- | 0-20 |
Name: CA 15.3 (Roche)
Mnemonic: C153RD
Units: U/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: C153RD
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-29 | 0- | 0-29 |
CA 19.9
Name: CA 19.9 (Beckman)
Mnemonic: CA199
Units: U/mL
Method Code: default
Effective date: 01/04/2017
Mnemonic: CA199
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-54 | 0- | 0-54 |
Name: CA 19.9 (Roche)
Mnemonic: C199RD
Units: U/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: C199RD
Units: U/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0-34 | 0- | 0-34 |
Carcinoembryonic Antigen
Name: Carcinoembryonic Antigen (Beckman)
Mnemonic: CEA
Units: ng/mL
Method Code: default
Effective date: 05/31/2024
Mnemonic: CEA
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0.0-5.0 | 0- | 0.0-5.0 |
Name: Carcinoembryonic Antigen (Roche)
Mnemonic: CEARD
Units: ng/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: CEARD
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0.0-3.7 | 0- | 0.0-3.7 |
Prostate Specific Antigen
Name: Prostate Specific Antigen (Beckman)
Mnemonic: PSA
Units: ng/mL
Method Code: default
Effective date: 12/02/2015
Mnemonic: PSA
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0.00-4.00 | 0- | 0.00-4.00 |
Name: Prostate Specific Antigen (Roche)
Mnemonic: PSARD
Units: ng/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: PSARD
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0-39y | 0.00-2.00 | ||
| 40y-49y | 0.00-2.50 | ||
| 50y-59y | 0.00-3.50 | ||
| 60y-69y | 0.00-4.50 | ||
| 70y-79y | 0.00-6.50 | ||
| 80y- | 0.00-7.20 | ||
Prostate Specific Antigen Screen
Name: Prostate Specific Antigen Screen (Beckman)
Mnemonic: PSASCR
Units: ng/mL
Method Code: default
Effective date: 01/25/2019
Mnemonic: PSASCR
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0- | 0.00-4.00 | 0- | 0.00-4.00 |
Name: Prostate Specific Antigen Screen (Roche)
Mnemonic: PSASRD
Units: ng/mL
Method Code: default
Effective date: 09/02/2026
Mnemonic: PSASRD
Units: ng/mL
Method Code: default
| Female | Male | ||
|---|---|---|---|
| Age | Range | Age | Range |
| 0-39y | 0.00-2.00 | ||
| 40y-49y | 0.00-2.50 | ||
| 50y-59y | 0.00-3.50 | ||
| 60y-69y | 0.00-4.50 | ||
| 70y-79y | 0.00-6.50 | ||
| 80y- | 0.00-7.20 | ||
Prostate Specific Antigen, Free
Name: Prostate Specific Antigen, Free (Beckman)
Mnemonic: PSAF
Units: ng/mL
Method Code: default
Mnemonic: PSAF
Units: ng/mL
Method Code: default
Name: Prostate Specific Antigen, Free (Roche)
Mnemonic: PSAFRD
Units: ng/mL
Method Code: default Effective date: 09/02/2026
Mnemonic: PSAFRD
Units: ng/mL
Method Code: default Effective date: 09/02/2026